CFF Supporting Phase 1/2 Trial of Phage Therapy for P. aeruginosa Infections

BiomX has been given up to $5 million to support a clinical trial of BX004, a phage therapy to fight Pseudomonas aeruginosa

Pin
  1. CFF Supporting Phase 1/2 Trial of Phage Therapy for P. aeruginosa Infections
Notice label will go here